rs1085307451
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_138615.3(DHX30):c.2353C>T(p.Arg785Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R785H) has been classified as Pathogenic.
Frequency
Consequence
NM_138615.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with severe motor impairment and absent language Pathogenic:5
Criteria applied: PS2_VSTR,PM2_SUP,PP2,PP3 -
- -
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been reported de novo in multiple unrelated individuals with global developmental delay, intellectual disability, severe speech impairment, gait abnormalities, cerebral atrophy, and delayed myelination [PMID 29100085] -
- -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID: 29100085). In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.94 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.91 (>=0.6, sensitivity 0.72 and precision 0.9)]. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000426111 /PMID: 29100085 /3billion dataset). The variant has been previously reported as de novo in a similarly affected individual (PMID: 29100085). A different missense change at the same codon (p.Arg785His) has been reported to be associated with DHX30-related disorder (ClinVar ID: VCV000453272 /PMID: 29100085). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
not provided Pathogenic:2
- -
- -
Inborn genetic diseases Pathogenic:1
The c.2353C>T (p.R785C) alteration is located in exon 15 (coding exon 13) of the DHX30 gene. This alteration results from a C to T substitution at nucleotide position 2353, causing the arginine (R) at amino acid position 785 to be replaced by a cysteine (C). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been determined to be the result of a de novo mutation in multiple individuals with features consistent with DHX30-related neurodevelopmental disorder (Lessel, 2017; Ambry internal data). This amino acid position is highly conserved in available vertebrate species. Functional analysis demonstrated that protein with the p.R785C alteration had reduced ATPase activity, abnormal accumulation in the cytoplasm, increased propensity to form stress granules preventing normal translation, and a decreased rate of newly formed peptides (Lessel, 2017). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at